Home Our offer State of the art

State of the art

Alcimed assists its clients in the elaboration of state of the art, i.e. in the mapping and analysis of existing knowledge in a given field (scientific, technical, medical, …) at a given time, allowing the identification of development opportunities.

Have a project? Contact our team!

State of the art Agency Consulting firm Experts SpecialistsHow we help you to assess the state of the art

The first step is to collect and select all relevant data (scientific publications, patents, etc.) and then to critically analyze them. At Alcimed, our teams carry out a state of the art assessment through an in-depth literature review that we complete by conducting targeted interviews in the field in question (experts, academic or industrial researchers, …) in order not only to understand the existing situation, but also to identify current and future research or development opportunities. Our clients can thus make informed strategic decisions based on the results of our investigations.

Contact us!


One of our customers, a pharmaceutical company, wanted to have an inventory and analysis of the connected devices on the market in the field of dermatology. Our teams carried out an in-depth state of the art assessment through different bibliographic sources (specialized medical journals, scientific database, patents, etc.) supplemented by expert interviews (key opinion leaders in the field, specialized start-ups, academic researchers, etc.), allowing our client to have visibility on the existing devices on the market, the fields of application, the operating modes, the regulatory status and the exploratory projects in progress. Our work enabled our client to be assured of having a complete mapping of the existing situation, in order to develop its roadmap according to our study, and to ultimately bring value to the current market.
We supported a biotechnology company in the realization of a state of the art in the field of oligonucleotides (oligonucleotides consist of short segments of nucleic acids: RNA or DNA). In a context of growth and consequently of evolution of its R&D activities, our client wanted to acquire oligonucleotides technologies or to establish a partnership with an expert company in the field. Having a limited vision of this complex domain at a global level, our client called our team to carry out a state of the art aiming at identifying and characterizing existing technologies and players worldwide, in order to select a panel of technologies and associated players of interest for our client. In the end, our project enabled our client to start discussions with 3 key selected players and to decide on an important investment for the future of its Research & Development activities.
Accompanying a cosmetic player in the realization of a global inventory of scientific knowledge concerning the link between emotions and perfume. Our client wanted to identify or generate scientifically ‘robust’ research avenues for the coming years and to ensure that they were not working on work already being done by others. The state of the art assessment carried out by our team allowed us to sort between purely “marketing” concepts and concepts that could be “scientifically documented” and to differentiate these concepts by region, allowing our client to identify relevant research leads for the launch of its future products.
For a player in the energy sector, Alcimed carried out a mapping of the technologies and associated suppliers allowing the transformation of air into water. Our team implemented a three-step approach: a first identification of the main market data and trends, followed by a screening of the identified technologies on the basis of their level of maturity and key performance criteria for our client – leading to a listing of the companies active in the most promising technologies -, and finally an analysis of the companies on more economic criteria to complete the evaluation of potential partners. Thanks to this state of the art, our client was able to identify and mobilize a network of key players for the development of its project.


Founded in 1993, Alcimed is an innovation and new business consulting firm, specializing in innovation driven sectors: life sciences (healthcare, biotech, agrifood), energy, environment, mobility, chemicals, materials, cosmetics, aeronautics, space and defence.

Our purpose? Helping both private and public decision-makers explore and develop their uncharted territories: new technologies, new offers, new geographies, possible futures, and new ways to innovate.

Located across eight offices around the world (France, Europe, Singapore and the United States), our team is made up of 220 highly-qualified, multicultural and passionate explorers, with a blended science/technology and business culture.

Our dream? To build a team of 1,000 explorers, to design tomorrow's world hand in hand with our clients.


    You have a project and want to discuss it with our explorers, write us ! One of our explorers will contact you shortly.